Raise Robotics | $7,800,000 | (Aug 6, 2025)
D-Tools Inc. | $12,000,000 | (Aug 6, 2025)
Kontext | $10,000,000 | (Aug 6, 2025)
Certified by Founder
Lodge
LoQus23 Therapeutics Ltd
start up
United Kingdom
- Cambridge, Cambridgeshire
- 02/10/2024
- Series A
- $46,550,175
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
- Industry Biotechnology Research
- Website https://loqus23.com/
- LinkedIn https://www.linkedin.com/company/loqus23-therapeutics-ltd/
OffDeal | $12,000,000 | (Aug 6, 2025)
Wattch | $6,000,000 | (Aug 6, 2025)
Vendict | $10,000,000 | (Aug 6, 2025)
NuCicer | $11,500,000 | (Aug 6, 2025)
OLarry | $10,000,000 | (Aug 6, 2025)
ketteQ | $20,000,000 | (Aug 6, 2025)
Lyric | $43,500,000 | (Aug 6, 2025)
Q.ANT | $71,676,650 | (Aug 5, 2025)
Afaxys, Inc. | $8,000,000 | (Aug 5, 2025)